TREATMENT OF ULCERATIVE COLITIS: EXPERIENCE OF USE OF METHOTREXATE IN SSC OF COLOPROCTOLOGY
- Authors: Mikhaylova T.L.1, Makarchuk P.A.1, Golovenko O.V.1, Veselov A.V.1, Mikhailova TL1, Makarchuk PA1, Golovenko OV1, Veselov AV1
-
Affiliations:
- Issue: No 2 (2011)
- Pages: 47-49
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278788
- ID: 278788
Cite item
Full Text
Abstract
About the authors
Tat'yana Leonidovna Mikhaylova
Pavel Aleksandrovich Makarchuk
Oleg Vladimirovich Golovenko
Aleksey Viktorovich Veselov
T L Mikhailova
P A Makarchuk
O V Golovenko
A V Veselov
References
- В.Г.Румянцев, Т.Л.Михайлова, Б.В.Киркин. Гормонально-зависимые формы воспалительных заболеваний толстой кишки и подход к их лечению // Российский журнал гастроэнтерол., гепатол. 2000. Т. 2. № 3. С. 46-49.
- Hanauer SB, D'Haens G. Medical Management of Ulcerative Colitis // S.R.Targan, F. Shanaban. Inflammatory Bowel Disease: from bench to bedside. Williams&Wilkins 1994:545-66.
- Oren R, Arben N, Odes S, et al. Methotrexate in chronic active ulcerative colitis: a double-blind, randomized, Israeli multicenter trial. Gastroenterology 1996;110:1416-21.
- Mate-Jimenez J, Hermida C, Cantero-Perona J, et al. 6-mercaptopurine or methotrexate added to prednisone induces and maintans remission in steroid dependent inflammatory bowel disease. Eur J Gastroenterol Hepatol 2000;12:1227-33.
- Kozarek RA, Patterson DJ, Gelfand MD, et al. Methotrexate induces clinical and histologic remission in patient with refractory inflammatory bowel disease. Ann Intern Med 1989;110:353-56.